Stocks in Action
News Home
Stocks in Action
Stock Recommendation
Result Analysis
Stock Market News
Mojo Premium
{{filter.label}}
Recently Visited
{{scheme.stockprice}} arrow {{scheme.chgp}}%
Premium
{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}
{{scheme.scoreText}} | Score {{scheme.score}}
{{scheme.score}}
{{scheme.score}}
{{scheme.scoretext}}
{{ scheme.tag }}
Most Searched
{{scheme.stockprice}} arrow {{scheme.chgp}}%
Premium
{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}
{{scheme.scoreText}} | Score {{scheme.score}}
{{scheme.score}}
{{scheme.score}}
{{scheme.scoretext}}
{{ scheme.tag }}

No Matches Found
{{filter.label}}
Search results for {{searchTermHome}}
{{scheme.stockprice}} arrow {{scheme.chgp}}%
Premium
{{ scheme.tag == 'Stock' || scheme.tag == 'News' ? 'View Reco' : 'View Ratings' }}
{{scheme.scoreText}} | Score {{scheme.score}}
{{scheme.score}}
{{scheme.score}}
{{scheme.scoretext}}
{{ scheme.tag }}

No Matches Found

No Matches Found

Zhejiang Conba Pharmaceutical Co., Ltd.

Zhejiang Conba Pharmaceutical Hits Day Low of CNY 4.29 Amid Price Pressure

Zhejiang Conba Pharmaceutical Co., Ltd. faced a challenging trading session, with shares declining significantly. The company has struggled over various time frames, including a year-to-date drop and a notable decrease over the past decade. Despite these challenges, it maintains a dividend yield of 3.19%.

Zhejiang Conba Pharmaceutical Hits Day Low of CNY 4.29 Amid Price Pressure
Aug 24 2026 05:12 PM IST
share
Share Via
{{stock_short.stock.stock_name.value}}
{{stock_short.stock.price.value}}
{{stock_short.stock.price_difference.value}} ({{stock_short.stock.price_percentage.value}}%)
{{ra.field}}
{{ra.stock_return.chgp}}%
{{ra.sensex_return.chgp}}%
{{stock_short.result_details[0].header}}
{{stock_short.result_details[0].latest.to_period}}
{{stock_short.result_details[0].latest.from_period}}
Change%
{{latest.field}}
{{latest.to}}{{latest.value_suffix}}
{{latest.from}}{{latest.value_suffix}}
{{latest.per}}
Figures in Rs cr

Zhejiang Conba Pharmaceutical Adjusts Valuation Amid Mixed Financial Signals and Growth Metrics

Zhejiang Conba Pharmaceutical Co., Ltd. has recently experienced a change in its evaluation, reflecting shifts in valuation and quality metrics. The company now boasts an attractive valuation grade, supported by strong financial indicators, while also receiving an upgrade in quality, highlighting its solid operational foundation despite recent flat financial performance.

Apr 24 2026 03:33 PM IST
share
Share Via
Zhejiang Conba Pharmaceutical Adjusts Valuation Amid Mixed Financial Signals and Growth Metrics

Zhejiang Conba Pharmaceutical Hits Day Low Amid Price Pressure at CNY 4.04

Zhejiang Conba Pharmaceutical Co., Ltd. faced a notable decline in stock performance, dropping 6.02% on March 23, 2026. Over the past week and month, the stock has decreased by 8.56% and 8.35%, respectively. The company has a market capitalization of CNY 11,156 million and a dividend yield of 3.46%.

Mar 24 2026 05:14 PM IST
share
Share Via
Zhejiang Conba Pharmaceutical Hits Day Low Amid Price Pressure at CNY 4.04

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via
{{list.post_title_sep}}

{{list.post_title}}

{{list.post_excerpt}}

{{list.post_date_sep}}
share
Share Via
Our weekly and monthly stock recommendations are here
Stock of the Week
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
Upgrade to Unlock the Latest Stock of the Week
Stock of the Month
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Upgrade to Unlock the Latest Stock of the Month
Most Read
Quarterly Earnings Review: Mixed Results Mark Jun-2026 with Large Caps Leading Profit Growth
Sep 23 2026 09:00 PM IST
share
Share Via
Ujjivan Small Joins Mojo Stocks List Following Stellar Q1 Financials
Sep 23 2026 08:50 PM IST
share
Share Via
Golden Cross Forms in Nova Iron & Steel Ltd — Mixed Technical Signals and Micro-Cap Caveats
Sep 23 2026 06:20 PM IST
share
Share Via
Vedanta Ltd. Forms Death Cross Signalling Potential Bearish Trend
Sep 23 2026 06:00 PM IST
share
Share Via
Golden Cross Forms in Manaksia Ltd Amid Mixed Technical Signals and Improving Momentum
Sep 23 2026 06:00 PM IST
share
Share Via
Lupin Ltd. Forms Death Cross, Signalling Potential Bearish Trend
Sep 23 2026 06:00 PM IST
share
Share Via
Golden Cross Forms in Fynx Capital Ltd — On a Day the Stock Gained 3.41%. What the Mixed Signals Mean
Sep 23 2026 06:00 PM IST
share
Share Via